Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 10, 2024
January 12, 2024
5176fb4c-a3d2-4aaf-85d0-dd246f7a9db1
Related Documents
Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry
Guidance DocumentApril 1, 2024Center for Drug Evaluation and Research
Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry
Guidance DocumentJuly 9, 2019Center for Drug Evaluation and Research
Q2(R2) Validation of Analytical Procedures
Guidance DocumentMarch 6, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox